Medical Director of Leukemia – MedStar Georgetown University Hospital

Position: Medical Director of Leukemia at the MedStar Georgetown University Comprehensive Cancer Center

Location: Washington, DC
Hospital Appointment: MedStar Georgetown University Hospital
Cancer Network Affiliation:  John Theurer Cancer Center / Regional Cancer Care Associates (RCCA)
Academic Appointment: Georgetown University College of Medicine
Department: Hematology & Oncology

The MedStar Georgetown Lombardi Comprehensive Cancer Center, an NCI-designated comprehensive cancer center in Washington, D.C., is seeking an accomplished and visionary Medical Director for the Leukemia Program. This leadership role provides a unique opportunity for a board-certified/board-eligible Hematologist/Oncologist with expertise in Leukemia to lead and expand the program across MedStar Georgetown University Hospital and the MedStar Health system.

The successful candidate will join a collaborative, multidisciplinary team of nationally recognized experts in Lymphoma, Myeloma, Blood and Marrow Stem Cell Transplantation, and Cellular Therapy, all working together within a highly supportive environment. This position offers outstanding clinical, research, and academic opportunities, including collaboration with Hackensack Meridian Health’s John Theurer Cancer Center (JTCC), the NCI consortium partner for Georgetown. This partnership provides access to a large, diverse patient population and robust resources for clinical trials, translational research, and Phase I studies, supporting the development of cutting-edge treatments for leukemia patients.

Position Overview

The Medical Director of the Leukemia Program will lead all aspects of the Leukemia Disease Group, including clinical operations, programmatic development, clinical trials, and research initiatives. The primary objective is to further expand and elevate the established leukemia program, transforming it into a destination site for leukemia care and innovation within the MedStar Health system.

Key Responsibilities

• Leading the development, growth, and vision of the Leukemia Program, ensuring the highest standards of patient care, research, and education.
• Collaborating with JTCC to advance clinical trials, investigator-initiated studies, and translational research across the NCI consortium.
• Partnering with BMT/Cell Therapy, Lymphoma, and Myeloma teams to create seamless, multidisciplinary care pathways for leukemia patients.
• Expanding clinical and translational research efforts, including Phase I trials and access to advanced therapies such as CAR-T cell therapy and other novel cellular treatments.
• Utilizing the state-of-the-art NGS platform for precision diagnostics and personalized treatment strategies in both clinical care and research.
• Developing and mentoring a team of advanced practice providers, clinical and research nurses, and support staff dedicated to the leukemia and hematologic malignancies programs.
• Engaging in teaching and mentorship for hematology/oncology fellows, medical students, and residents affiliated with Georgetown University School of Medicine.

This position also offers the opportunity to shape the future of leukemia care across MedStar Health’s expansive network of 10 hospitals and hundreds of ambulatory sites throughout the Maryland, Virginia, and Washington, D.C. regions.

Key Opportunities and Resources

• Leadership Role: Serve as the Medical Director for the Leukemia Program, with the opportunity to build and expand a premier destination site for leukemia care.
• NCI-Designated Cancer Center: Work within the only NCI-designated comprehensive cancer center in Washington, D.C., providing access to cutting-edge resources, clinical trials, and multidisciplinary collaboration.
• Academic & Research Support: Collaborate with JTCC, a leader in hematologic malignancies, to conduct Leukemia studies across the NCI consortium, supporting both investigator-initiated and industry-sponsored trials.
• Cellular Therapy & Phase I Support: Access a dedicated cellular therapy team, Phase I trial capabilities, and the ability to offer CAR-T cell therapies and other advanced treatment options.
• NGS Platform: Leverage a state-of-the-art next-generation sequencing (NGS) platform for precision oncology and clinical decision-making.
• Comprehensive Program Support: Work within a robust infrastructure, including advanced practice providers (APNs), clinical and research nurses, and administrative staff, dedicated to the Hematologic Malignancies Program.
• Outstanding Compensation: Competitive salary, relocation assistance, and comprehensive benefits package.

Required Qualifications

The ideal candidate will be an accomplished physician-leader with expertise in leukemia and a passion for advancing patient care, research, and education.

Required qualifications include:

• MD, MD/PhD, DO, or equivalent degree required.
• Board certification in Hematology and/or Medical Oncology.
• Fellowship training in Hematologic Malignancies, with specific expertise in leukemia.
• Minimum of 5 years of clinical experience post-fellowship, with demonstrated leadership experience preferred.
• A strong record of clinical excellence, peer-reviewed publications, and clinical trial participation.
• Experience working within a multidisciplinary cancer care environment.
• Commitment to advancing patient-centered care, education, and health equity.
• Strong interpersonal and communication skills, with a collaborative, team-oriented approach.

Preferred qualifications include:

• Leadership experience within an academic medical center or NCI-designated cancer center.
• Prior experience in developing or leading a Leukemia Program, including clinical, research, and administrative components.
• An interest in advancing precision oncology, NGS-based diagnostics, and novel therapeutics.
• Experience with clinical trials, investigator-initiated studies, and translational research in leukemia.

Washington, D.C., home to MedStar Georgetown University Hospital, offers an exceptional environment for medical professionals, combining world-class healthcare, research, and cultural richness.

About the Lombardi Comprehensive Cancer Center (NCI-Designated)

The MedStar Georgetown Lombardi Comprehensive Cancer Center is the only NCI-designated comprehensive cancer center in the Washington, D.C. region and an integral part of the Georgetown University School of Medicine. It serves as the flagship cancer center for MedStar Health, a 10-hospital system with an extensive ambulatory network across Maryland, Virginia, and the District of Columbia.

As part of the NCI consortium with JTCC, the center offers access to leading-edge clinical trials, cellular therapies, and advanced diagnostics, providing exceptional opportunities for academic collaboration, research, and innovation. The program is also deeply committed to health equity, ensuring that advanced cancer care reaches diverse communities across the region.

Originally a small clinic for cancer patients, Georgetown Lombardi has grown into a state-of-the-art cancer center spanning over 240,000 square feet of clinic and research space. It became the 16th NCI-designated Comprehensive Cancer Center in the U.S. in 1974 and remains a leader in groundbreaking cancer research and treatment.

FACT-Accredited Programs at MedStar Georgetown University Hospital

The incoming Director will join a program that is uniquely positioned to leverage three FACT-accredited programs that support groundbreaking research and patient care:

• Bone Marrow Transplant (BMT) Program: Recognized for excellence in hematopoietic stem cell transplantation, offering innovative treatment protocols for blood cancers and disorders.
• Blood & Marrow Collection Program: The largest in the country and the gold standard in donor stem cell collection, ensuring the highest quality standards in cellular therapy.
• Cell Therapy Manufacturing (CTMF) Lab: A cutting-edge facility dedicated to producing novel cell-based therapies, supporting research and clinical applications in immunotherapy and regenerative medicine.

These programs offer a robust foundation for clinical advancements, research collaboration, and expansion of cellular immunotherapy initiatives, positioning MedStar Georgetown as a leader in stem cell transplantation and cellular therapy.

The official logo of Georgetown University, a globally recognized institution known for its leadership in academics, research, and healthcare innovation.

Georgetown University School of Medicine

As one of the nation’s premier academic medical institutions, the Georgetown University School of Medicine has a rich tradition of excellence in medical education, biomedical research, and patient-centered care. With over 700 medical students and 1,200 faculty members, the school is committed to training future leaders in medicine while fostering an environment of discovery and innovation. The medical school’s strong emphasis on mentorship, ethics, and interdisciplinary collaboration provides an unparalleled foundation for faculty seeking to engage in academic medicine and research.

The newly opened Verstandig Pavilion at MedStar Georgetown University Hospital enhances patient care with 31 advanced operating rooms, 32 private emergency department rooms, and 156 private inpatient rooms. A testament to innovation in healthcare and medical research.

MedStar Georgetown University Hospital & MedStar Health System

MedStar Health is the largest healthcare provider in the Maryland-D.C. region, operating 10 hospitals, over 300 outpatient locations, and a comprehensive academic health system affiliated with Georgetown University. MedStar’s commitment to cutting-edge research, medical education, and advanced patient care makes it a leader in oncology, transplant medicine, and cellular immunotherapy. As part of MedStar Health, the Medical Director of the Leukemia Program will have access to vast clinical and research resources, a multidisciplinary network of specialists, and robust institutional support for program expansion.

Our centers of excellence include cancer care, neurosciences, gastroenterology, orthopedics, and transplant medicine. We are deeply committed to patient-centered care, research innovation, and associate satisfaction, fostering an inclusive environment where diverse perspectives lead to improved patient outcomes.

MedStar Georgetown University Hospital is one of the largest healthcare providers in the Washington, DC area and a premier academic medical center.

Key Institutional Highlights

• The only NCI-designated comprehensive cancer center (Georgetown Lombardi Comprehensive Cancer Center) in the Washington, D.C. region
• FACT Accreditation for Bone Marrow and Stem Cell Transplantation
• Magnet® Recognition recipient for nursing excellence (among only 1% of hospitals nationally to receive this designation five or more times)
• Home to one of the nation’s highest-volume transplant programs through the MedStar Georgetown Transplant Institute
• First hospital in the Washington, D.C. area to offer Proton Therapy
• Recently opened state-of-the-art Verstandig Pavilion featuring:
  • 487,400 square foot
  • 156 universal ICU and IMC patient rooms
  • 31-OR surgery suite, including Hybrid OR and 2 iMRI
  • 32 private Emergency Department rooms
  • 156 private patient rooms
  • Modern facilities designed for optimal patient care

Academic Excellence

• Academic and research affiliation with Georgetown University
• Robust medical residency programs
• AACN/Vizient Nurse Residency Program
• Ranked by U.S. News & World Report as one of the region’s best hospitals
• Recognized as “high performing” in multiple specialties and procedures
• Partnership with John Theurer Cancer Center & RCCA

The John Theurer Cancer Center, part of Hackensack University Medical Center and Hackensack Meridian Health, is a nationally recognized leader in bone marrow transplantation, CAR-T therapy, and cellular immunotherapy.

Partnership with John Theurer Cancer Center & RCCA

Through a strategic collaboration with the John Theurer Cancer Center (JTCC) and Regional Cancer Care Associates (RCCA), MedStar Georgetown enhances access to one of the most comprehensive hematologic malignancy and cellular therapy programs on the East Coast. JTCC is nationally recognized for its expertise in bone marrow transplantation, CAR-T therapy, and innovative immunotherapy approaches, treating over 6,000 patients annually. This partnership allows for shared clinical trials, expanded patient referral networks, and access to novel therapies, positioning MedStar Georgetown as a leader in transplant and cellular therapy.

Experience the beauty of Washington, D.C., with stunning cherry blossoms at the Jefferson Memorial, vibrant cultural landmarks, and an unparalleled quality of life.

Living in Washington, D.C., Maryland, and Northern Virginia

The Washington, D.C. metropolitan area offers an unparalleled combination of professional opportunities, cultural richness, and quality of life. Georgetown, located along the picturesque Potomac River, is known for its historic charm, vibrant arts scene, and world-class dining. The area provides easy access to Smithsonian museums, the Kennedy Center, and some of the nation’s top public and private schools. With three major airports, excellent public transportation, and proximity to the NIH, FDA, and top biotech hubs, D.C. is an ideal location for hematologist/oncologists seeking a balance between academic excellence and an enriching lifestyle. Whether enjoying outdoor activities along the Chesapeake Bay, exploring the scenic vineyards of Virginia wine country, or immersing in the region’s diverse cultural experiences, this is a prime destination for professionals and families alike.

Why Join MedStar Georgetown University Hospital?

MedStar Georgetown University Hospital is a leading academic medical center, home to the Lombardi Comprehensive Cancer Center, a National Cancer Institute (NCI)-designated cancer center. The institution is committed to groundbreaking research, outstanding patient care, and excellence in medical education.

As the Director of the Stem Cell Transplant and Cellular Immunotherapy Program, you will have the unique opportunity to shape the future of cellular therapy and immuno-oncology within a dynamic and supportive academic environment.

Join us in advancing the next frontier of hematologic malignancy treatment and cellular immunotherapy at MedStar Georgetown University Hospital.

Application Process

This search is being led by Academic Med, a retained executive search firm that specializes in physician and scientific leadership recruitment for academic health systems and cancer centers. Interested candidates should submit a CV and Cover Letter to Jim Hagood, Managing Director & Co-Founder of Academic Med via email: jim@academic-med.com

EEO
MedStar Georgetown University Hospital is an equal opportunity employer committed to fostering a diverse and inclusive workplace. We welcome applications from all qualified candidates, regardless of race, ethnicity, gender, sexual orientation, disability, veteran status, or any other protected characteristic. We believe that diversity strengthens our workforce and enhances patient care, and we are dedicated to creating an environment where all individuals have the opportunity to thrive.